WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
News & Events
Maps & Locations
PATIENT AND VISITOR INFORMATION
PREVENTION AND SCREENING
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Content Block Control
RETURN TO SEARCH RESULTS
Phase I Study of Oral Clofarabine Consolidation in Adults Aged 60 and Older with Acute Myeloid Leukemia
Myeloid and Monocytic Leukemia
Map and Directions
This study for patients with Acute Myeloid Leukemia (AML) who are at least age 60 years or older and are currently in remission.
The purposes of this study are to find out what effects (good and bad) the cancer drug clofarabine has when given to patients, to determine the best dose of clofarabine, and to determine whether clofarabine is effective in keeping AML from coming back (relapse).
Approximately 30 patients with AML who are 60 years of age or older will participate in this study at Washington University.
(Links will take you off this web site)
Internal Protocol Documents (requires Siteman administrative database password)
© 2009 All rights reserved